BUY Divi's Laboratories — Rajesh Palviya, 26 Aug 2026

byRajesh Palviya, Axis SecuritiesHorizon: NA (inferred Swing (≤2wk))26 Aug 2026via ET Now

Entry₹8,744.5Inferred

Target₹9,200

Stop loss₹8,550-2.22% risk

Exit₹9,20028 Aug 2026, 10:00 am

Target hit+5.21%0.00%upside left

Follow Rajesh Palviya for new calls(26% target hit, 155 closed calls)Get alerts Watch DIVISLAB for new buy/sell callsGet alerts See 2 active Swing calls on DIVISLAB

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 28 Aug 2026

6 supporting1 opposing

Supports the BUY call (6)

PNB Housing, Divi's Labs Touch 52-Week Highs on Aug 26

NewsGoogle News·26 Aug · yesterday

2 advisors have active short-term BUY calls on this stock, all issued in the last 14 days

Advisor consensus · adjacent horizon·26 Aug · yesterday

Divi’s, TVS Motors, Dixon See Bullish Signals: Analyst

NewsGoogle News·26 Aug · 2d ago

Divis Laboratories fixes July 24 record date for ₹30 dividend

NewsGoogle News·25 Aug · 3d ago

Divi's Laboratories recommends ₹30 dividend, outlines TDS compliance

NewsGoogle News·23 Aug · 4d ago

Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (1)

Indian Pharma Stocks Face Volatility After US Tariff Proposal

NewsGoogle News·14 Aug · 2w ago

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

BUY Divi's Laboratories Limited — Rajesh Palviya, Axis Securities

AI Assessment